Department of Respiratory Medicine, Bristol Royal Infirmary, Bristol, UK
Chron Respir Dis. 2016 May;13(2):173-88. doi: 10.1177/1479972316631139. Epub 2016 Feb 15.
Breathlessness and impaired quality of life are prominent features in patients with severe emphysema even when conventional methods of treatment are optimal. Lung volume reduction using endobronchial management for emphysema has emerged as a new method to relieve symptoms and improve lung function tests in this group. The endobronchial valves (EBVs) are the most widely used treatment. This article outlines current criteria of patients' selection with literature review and evidence of efficacy. Complications of EBV insertion as well as current shortfalls of this method of treatment are also discussed.
呼吸困难和生活质量受损是严重肺气肿患者的突出特征,即使采用常规治疗方法也是如此。支气管内管理肺气肿肺减容术已成为缓解该组症状和改善肺功能测试的新方法。支气管内瓣膜 (EBV) 是最广泛使用的治疗方法。本文通过文献回顾和疗效证据概述了当前患者选择标准。还讨论了 EBV 插入的并发症以及该治疗方法的当前不足之处。